(TORONTO) November 2001.... GlaxoSmithKline (GSK) is pleased to announce a partnership with The Health Television System Inc. - Canada's leader in direct to patient education programming and distribution.

Launching May 2002,the partnership initiative focuses on symptom management education and is directed to cancer patients and their families. It will be underwritten by GSK's revolutionary drug, Zofran® which controls the debilitating nausea that is a side effect with 80% of cancer treatments.

Under the terms of the partnership, The Health Television System Inc. will develop and produce a video/DVD that will be seen by 1.2 million patients and their families on its hospital-based television network, Healthtv The Health Television System Inc. will hold copyright on the product to enable further distribution through its relationship-based infrastructure - which includes cancer clinics.

Michael Fleming, Vice President, HIV, Oncology, Vaccines at GlaxoSmithKline explains, "Healthtv is not mass media. It is targeted and takes an educative rather than a journalistic approach. The producers did their homework on our product and the end result is an effective tool that we have also ordered for use by our reps."

"Healthcare professionals and patients have been requesting education on controlling nausea," says Kathy Kastner, CEO and Director of Programming for The Health Television System Inc., "We're pleased that GSK - with its highly regarded anti-emetic product - underwriting the initiative".

GSK - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of life by enabling humans to do more, feel better and live longer.

The Health Television System Inc., which is free of charge to patients, broadcasts in the largest teaching hospitals in Canada. All content on Healthtv is developed in collaboration with relevant national disease associations and Health Canada.